KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Net Cash Flow (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Net Cash Flow data on record, last reported at -$28.1 million in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 164.83% year-over-year to -$28.1 million; the TTM value through Dec 2025 reached -$119.4 million, up 23.53%, while the annual FY2025 figure was -$119.4 million, 23.53% up from the prior year.
  • Net Cash Flow reached -$28.1 million in Q4 2025 per IDXX's latest filing, down from $44.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $201.6 million in Q3 2023 and bottomed at -$122.0 million in Q1 2025.
  • Average Net Cash Flow over 5 years is -$9.7 million, with a median of -$9.8 million recorded in 2022.
  • Peak YoY movement for Net Cash Flow: skyrocketed 7091.35% in 2022, then tumbled 3021.01% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $104000.0 in 2021, then surged by 7091.35% to $7.5 million in 2022, then skyrocketed by 1472.03% to $117.6 million in 2023, then plummeted by 109.02% to -$10.6 million in 2024, then plummeted by 164.83% to -$28.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$28.1 million in Q4 2025, $44.2 million in Q3 2025, and -$13.5 million in Q2 2025.